Page last updated: 2024-08-26

wr 159412 and wr 158122

wr 159412 has been researched along with wr 158122 in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-199010 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elslager, EF; Hutt, MP; Jacob, P; Johnson, J; Rane, L; Temporelli, B; Werbel, LM; Worth, DF1
Fukunaga, JY; Hansch, C; Jow, PY1
Fukunaga, JY; Hansch, C; Steller, EE1
Degnan, MJ; Werbel, LM1
Crippen, GM; Ghose, AK3
Battershell, C; Hopfinger, AJ; Malhotra, D1
Crippen, GM1
Schmidt, LH1

Other Studies

10 other study(ies) available for wr 159412 and wr 158122

ArticleYear
Folate antagonists. 15. 2,3-Diamino-6-(2-naphthylsulfonyl)quinazoline and related 2,4-diamino-6-[(phenyl and naphthyl)sulfinyl and sulfonyl]quinazolines, a potent new class of antimetabolites with phenomenal antimalarial activity.
    Journal of medicinal chemistry, 1979, Volume: 22, Issue:10

    Topics: Animals; Antimalarials; Bacteria; Chemical Phenomena; Chemistry; Chickens; Drug Resistance; Folic Acid Antagonists; Haplorhini; Malaria; Mice; Plasmodium; Quinazolines

1979
Quantitative structure-activity relationships of antimalarial and dihydrofolate reductase inhibition by quinazolines and 5-substituted benzyl-2,4-diaminopyrimidines.
    Journal of medicinal chemistry, 1977, Volume: 20, Issue:1

    Topics: Animals; Antimalarials; Escherichia coli; Folic Acid Antagonists; Mathematics; Mice; Microbial Sensitivity Tests; Pyrimidines; Quinazolines; Streptococcus; Structure-Activity Relationship

1977
Inhibition of dihydrofolate reductase. Structure-activity correlations of quinazolines.
    Journal of medicinal chemistry, 1976, Volume: 19, Issue:5

    Topics: Binding Sites; Folic Acid Antagonists; Liver; Molecular Conformation; Quinazolines; Structure-Activity Relationship

1976
Synthesis and antimalarial and antitumor effects of 2-amino-4-(hydrazino and hydroxyamino)-6-[(aryl)thio]quinazolines.
    Journal of medicinal chemistry, 1987, Volume: 30, Issue:11

    Topics: Animals; Antimalarials; Antineoplastic Agents; Hydrazines; Hydroxylamines; Mice; Quinazolines; Structure-Activity Relationship

1987
General distance geometry three-dimensional receptor model for diverse dihydrofolate reductase inhibitors.
    Journal of medicinal chemistry, 1984, Volume: 27, Issue:7

    Topics: Animals; Binding Sites; Chemical Phenomena; Chemistry, Physical; Crystallography; Folic Acid Antagonists; Liver; Models, Chemical; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Rats; Structure-Activity Relationship; Triazines

1984
Combined distance geometry analysis of dihydrofolate reductase inhibition by quinazolines and triazines.
    Journal of medicinal chemistry, 1983, Volume: 26, Issue:7

    Topics: Chemical Phenomena; Chemistry; Folic Acid Antagonists; Molecular Conformation; Quinazolines; Streptococcus; Structure-Activity Relationship; Triazines

1983
Quantitative structure-activity relationship by distance geometry: quinazolines as dihydrofolate reductase inhibitors.
    Journal of medicinal chemistry, 1982, Volume: 25, Issue:8

    Topics: Chemical Phenomena; Chemistry, Physical; Energy Metabolism; Folic Acid Antagonists; Molecular Conformation; Quinazolines; Receptors, Drug; Structure-Activity Relationship

1982
Inhibition of dihydrofolate reductase: structure-activity correlations of quinazolines based upon molecular shape analysis.
    Journal of medicinal chemistry, 1981, Volume: 24, Issue:7

    Topics: Chemical Phenomena; Chemistry, Physical; Folic Acid Antagonists; Models, Molecular; Molecular Conformation; Quinazolines; Structure-Activity Relationship

1981
Quantitative structure-activity relationships by distance geometry: systematic analysis of dihydrofolate reductase inhibitors.
    Journal of medicinal chemistry, 1980, Volume: 23, Issue:6

    Topics: Binding Sites; Folic Acid Antagonists; Ligands; Models, Biological; Models, Molecular; Molecular Conformation; Structure-Activity Relationship; Thermodynamics

1980
Studies on the 2,4-diamino-6-substituted quinazolines. III. The capacity of sulfadiazine to enhance the activities of WR-158,122 and WR-159,412 against infections with various drug-susceptible and drug-resistant strains of Plasmodium falciparum and Plasmo
    The American journal of tropical medicine and hygiene, 1979, Volume: 28, Issue:5

    Topics: Animals; Aotus trivirgatus; Drug Combinations; Drug Resistance, Microbial; Female; Haplorhini; Malaria; Male; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Quinazolines; Sulfadiazine

1979